Cite
HARVARD Citation
Lombardi, R. et al. (2021). HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer. Molecular oncology. 15 (4), pp. 1005-1023. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lombardi, R. et al. (2021). HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer. Molecular oncology. 15 (4), pp. 1005-1023. [Online].